Dein Körper - Dein Leben ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  16.1% 26.1% 21.7% 20.1% 19.9%  
Credit score (0-100)  12 3 4 5 5  
Credit rating  BB B B B B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  113 0 0 0 0  
Gross profit  44.4 92.0 13.3 28.6 97.9  
EBITDA  -2.7 36.8 13.3 -1.5 -44.8  
EBIT  -2.7 36.8 13.3 -1.5 -44.8  
Pre-tax profit (PTP)  -2.7 32.9 12.6 -1.9 -45.3  
Net earnings  -2.7 32.9 4.4 -1.5 -45.7  
Pre-tax profit without non-rec. items  -2.7 32.9 12.6 -1.9 -45.3  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  -1.7 31.2 35.6 34.1 -11.6  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  23.5 34.7 38.2 37.3 19.5  

Net Debt  -23.5 -34.7 -37.7 -28.4 -19.5  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  113 0 0 0 0  
Net sales growth  0.0% -100.0% 0.0% 0.0% 0.0%  
Gross profit  44.4 92.0 13.3 28.6 97.9  
Gross profit growth  0.0% 107.2% -85.5% 115.4% 241.9%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  -47.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  24 35 38 37 20  
Balance sheet change%  0.0% 47.5% 10.1% -2.4% -47.7%  
Added value  44.4 36.8 13.3 -1.5 -44.8  
Added value %  39.3% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 -1.0 0.0 0.0 0.0  
EBIT trend  -1.0 1.0 2.0 -1.0 -2.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  -2.4% 0.0% 0.0% 0.0% 0.0%  
EBIT %  -2.4% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -6.0% 40.1% 100.0% -5.2% -45.8%  
Net Earnings %  -2.4% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  -2.4% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  -2.4% 0.0% 0.0% 0.0% 0.0%  
ROA %  -10.5% 122.9% 36.4% -4.0% -130.9%  
ROI %  0.0% 235.8% 39.8% -4.3% -262.8%  
ROE %  -11.4% 120.2% 13.1% -4.4% -170.6%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  -6.7% 90.0% 93.2% 91.4% -37.4%  
Relative indebtedness %  22.4% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  1.5% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  885.0% -94.2% -283.4% 1,895.1% 43.5%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.9 10.0 14.7 11.6 0.6  
Current Ratio  0.9 10.0 14.7 11.6 0.6  
Cash and cash equivalent  23.5 34.7 37.7 28.4 19.5  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  20.9% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -1.7 31.2 35.6 34.1 -11.6  
Net working capital %  -1.5% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0